Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02618031 · ClinicalTrials.gov registry record · Phase 1
The Capillary Index Score Trial
A Phase 1 study of Ischemic Stroke and Acute Stroke, sponsored by Firas Al-Ali.
- Completed
- Registry status
- Phase 1
- Development phase
- 57
- Enrollment target
- 6
- Study locations
NCT02618031 is a Phase 1 study of Ischemic Stroke and Acute Stroke that has completed, run by Firas Al-Ali. The registered enrollment target is 57 participants, below the 1,463-participant average among 66 other Ischemic Stroke trials with a reported enrollment target (96% lower). The trial reports 6 study locations across 5 states.
The verdict
NCT02618031, a Phase 1 study of Ischemic Stroke and Acute Stroke, has completed, sponsored by Firas Al-Ali.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 57 participants
- Enrollment target
- 6
- Study locations
Study Summary
This study seeks to investigate the capillary index score (CIS) to further improve patient selection of endovascular treatment (EVT) in acute ischemic stroke (AIS). The hypothesis or idea being tested: Patients with favorable CIS who are successfully revascularized with EVT can have successful outcomes with an extended time window for treatment.
Conditions Studied
Interventions
- PROCEDURE Endovascular Treatment (EVT)
Study Locations (6)
New York
- New York University Langone Medical Center - New York
- Rochester General Hospital - Rochester
Georgia
- WellStar Atlanta Medical System - Atlanta
North Carolina
- University of North Carolina Hospital - Chapel Hill
Ohio
- Akron General Medical Center - Akron
Vermont
- University of Vermont Medical Center - Burlington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2016-03-01 |
| Est. Completion | 2018-12-31 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02618031
The ClinicalTrials.gov registry entry for NCT02618031 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 57 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,463-participant average among 66 other Ischemic Stroke trials with a reported enrollment target (96% lower). The listed sponsor is Firas Al-Ali, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Ischemic Stroke appearing as the primary indexed condition, and to 1 intervention - of which Endovascular Treatment (EVT) is the first listed.
NCT02618031 reports 6 study locations spanning 5 distinct geographic areas - top geographies include New York, Georgia, North Carolina.
Frequently Asked Questions
What is clinical trial NCT02618031 about?
NCT02618031 is a clinical study titled "The Capillary Index Score Trial". This study seeks to investigate the capillary index score (CIS) to further improve patient selection of endovascular treatment (EVT) in acute ischemic stroke (AIS). The hypothesis or idea being tested: Patients with favorable CIS who are successfully revascularized with EVT can have successful out...
What is the current status of trial NCT02618031?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 57 participants. The study started on 2016-03-01. Estimated completion is 2018-12-31.
What conditions does trial NCT02618031 study?
This clinical trial studies the following conditions: Ischemic Stroke, Acute Stroke, Brain Ischemia.
What interventions are being tested in trial NCT02618031?
The interventions under investigation include: Endovascular Treatment (EVT) (PROCEDURE).
Who is sponsoring clinical trial NCT02618031?
This trial is sponsored by Firas Al-Ali, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02618031 being conducted?
This trial has 6 study locations across Georgia, New York, North Carolina, Ohio, Vermont. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ischemic Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Verapamil for Neuroprotection in Stroke
RECRUITING · Phase 1
-
Psychedelic Healing: Adjunct Therapy Harnessing Opened Malleability
RECRUITING · Phase 1
-
A Safety and Tolerability Study of Neural Stem Cells (NR1) in Subjects With Chronic Ischemic Subcortical Stroke (ISS)
ACTIVE NOT RECRUITING · Phase 1
-
A Study of NCS-01 in Patients With Acute Ischemic Stroke
ACTIVE NOT RECRUITING · Phase 1
-
Functional Magnetic Resonance Imaging (fMRI) and Robot-Assisted Practice of Activities of Daily Living
COMPLETED · Phase 1
-
Safety/Feasibility of Autologous Mononuclear Bone Marrow Cells in Stroke Patients
COMPLETED · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.